Filters close
Newswise: Hackensack Meridian Hackensack University Medical Center is the First Hospital in the World to Use the Artificial Intelligence-Powered HYDROS™ Robotic System to perform Aquablation® Therapy to Treat Prostate Enlargement
Released: 16-Sep-2024 1:05 PM EDT
Hackensack Meridian Hackensack University Medical Center is the First Hospital in the World to Use the Artificial Intelligence-Powered HYDROS™ Robotic System to perform Aquablation® Therapy to Treat Prostate Enlargement
Hackensack Meridian Health

On the morning of Wednesday, September 4, 2024, Hackensack Meridian Hackensack University Medical Center became the first hospital in the world to treat patients with Aquablation® therapy using the new HYDROS™ Robotic System.

Newswise: Mount Sinai Health System Is First in Northeast to Use Blood Tests as an Early Detection Tool for Alzheimer’s Disease and Related Dementias in Patients
Released: 16-Sep-2024 12:05 PM EDT
Mount Sinai Health System Is First in Northeast to Use Blood Tests as an Early Detection Tool for Alzheimer’s Disease and Related Dementias in Patients
Mount Sinai Health System

Mount Sinai Health System today announced that they will be among the first in the world to deploy blood-based biomarkers (blood tests) and confirmatory tests for Alzheimer’s disease and related dementias to patients across primary and specialty care settings—early detection tools that have never before been offered to patients in the clinical setting—as part of the Davos Alzheimer’s Collaborative (DAC) Healthcare System Preparedness Accurate Diagnosis project.

Released: 16-Sep-2024 12:05 PM EDT
Estudio De Mayo Clinic Encuentra GlóBulos Blancos Disfuncionales Relacionados Con Un Mayor Riesgo De Melanoma
Mayo Clinic

Personas con una sobreabundancia de glóbulos blancos clonados, o linfocitos, que dañan su sistema inmunológico, una afección llamada linfocitosis monoclonal de células B (LMB), pueden tener un riesgo elevado de desarrollar diversas complicaciones de salud, incluido el melanoma, una forma de cáncer de piel.

Released: 16-Sep-2024 12:05 PM EDT
Testing a Revolutionary Treatment Against Progressive Multiple Sclerosis
Rutgers University-New Brunswick

Rutgers Health researchers will enroll primary or secondary progressive multiple sclerosis (p-MS) patients to see if an engineered immune cell therapy can halt the progression of the autoimmune disease.

Released: 16-Sep-2024 12:00 PM EDT
Expert Available: Neurodiversity Awareness in the National Spotlight
George Washington University

Democratic vice presidential candidate Tim Walz and his son, Gus, went viral when Gus was seen celebrating his dad’s acceptance speech at the DNC. ...

Newswise: Food insecurity in early life, pregnancy may be linked to higher chance of obesity in children, NIH-funded study finds
Released: 16-Sep-2024 11:10 AM EDT
Food insecurity in early life, pregnancy may be linked to higher chance of obesity in children, NIH-funded study finds
Environmental influences on Child Health Outcomes NIH

Children who faced food insecurity during early childhood—or whose mothers experienced it during pregnancy—had a higher body mass index (BMI) and more than 50% increased chance of developing obesity or severe obesity in childhood and adolescence, according to a new study funded by the NIH Environmental influences on Child Health Outcomes (ECHO) Program.

Newswise: FDA Approves First-of-Its-Kind Cardiac Stent for Babies
Released: 16-Sep-2024 11:05 AM EDT
FDA Approves First-of-Its-Kind Cardiac Stent for Babies
Children's Hospital Los Angeles

In 2022, a team from Children’s Hospital Los Angeles became the first in the world to implant a novel cardiac stent designed specifically for babies and young children. The stent is the first of its kind that can be expanded as a child grows—all the way to adult size.

Released: 16-Sep-2024 11:05 AM EDT
AANA Announces New RN/APRN Membership Category
American Association of Nurse Anesthesiology

AANA announced the creation of a new membership category for registered nurses and advanced practice registered nurses.

Not for public release

This news release is embargoed until 16-Sep-2024 11:00 AM EDT Released to reporters: 13-Sep-2024 3:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-Sep-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

13-Sep-2024 7:05 AM EDT
Study Finds Food Insecurity Increases Hospital Stays and Odds of Readmission
Wake Forest University School of Medicine

A new study from researchers at Wake Forest University School of Medicine shows that inpatient food insecurity, experienced by caregivers during their child’s hospitalization, is associated with not only longer hospital admissions but also significantly increased odds of readmission.

Newswise: Rethinking the Use of Melatonin as a Sleep Aid for Kids
Released: 16-Sep-2024 10:05 AM EDT
Rethinking the Use of Melatonin as a Sleep Aid for Kids
American Academy of Sleep Medicine (AASM)

A new survey from the American Academy of Sleep Medicine reveals that nearly half (45%) of parents have given melatonin to a child under the age of 18 to help him or her sleep.

Released: 16-Sep-2024 10:05 AM EDT
WashU Medicine Leads Two Major Pandemic Preparedness Research Projects
Washington University in St. Louis

WashU Medicine scientists lead two large, multicenter programs to develop vaccines and antibody-based therapies for understudied viruses with pandemic potential. The programs are supported by two grants from the National Institute for Allergy and Infectious Diseases (NIAID) totaling more than $30 million a year for three years.

Newswise: News Tip: September Is Sickle Cell Awareness Month – Johns Hopkins Medicine Experts Are Available for Interviews
Released: 16-Sep-2024 10:05 AM EDT
News Tip: September Is Sickle Cell Awareness Month – Johns Hopkins Medicine Experts Are Available for Interviews
Johns Hopkins Medicine

September is National Sickle Cell Awareness Month. Experts from Johns Hopkins Medicine who specialize in sickle cell disease are available to discuss health equity issues related to sickle cell disease.

Released: 16-Sep-2024 10:05 AM EDT
Notable Scientific Oral Abstracts and Late-Breaking Science to Be Presented at Otolaryngology’s Annual Meeting
American Academy of Otolaryngology - Head and Neck Surgery

The latest research and advances in otolaryngology-head and neck surgery will be presented during the AAO-HNSF 2024 Annual Meeting & OTO EXPOSM in Miami, Florida, September 28 – October 1.

Released: 16-Sep-2024 9:05 AM EDT
Xylyx Bio awarded $2.45M NIH SBIR grant from NIDDK to facilitate development of effective drugs for fibrotic liver disease
Xylyx Bio, Inc.

Award supports the development of a cell-based assay platform to help scientists discover and test drug candidates for liver fibrosis.

   
Newswise:  Montefiore Einstein Comprehensive Cancer Center Establishes New Immunotherapy Institute
Released: 16-Sep-2024 9:05 AM EDT
Montefiore Einstein Comprehensive Cancer Center Establishes New Immunotherapy Institute
Montefiore Einstein Comprehensive Cancer Center

The National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) has announced the new Marilyn and Stanley M. Katz Institute for Immunotherapy for Cancer and Inflammatory Disorders. Xingxing Zang, Ph.D., an international leader in developing novel immunotherapies, has been named its inaugural director.

Newswise: Hackensack Meridian Mountainside Medical Center Selected as Site for Landmark STEMI-DTU Clinical Trial
Released: 16-Sep-2024 9:00 AM EDT
Hackensack Meridian Mountainside Medical Center Selected as Site for Landmark STEMI-DTU Clinical Trial
Hackensack Meridian Health (Mountainside Medical Center)

Hackensack Meridian Mountainside Medical Center is honored to announce its selection as a site for the groundbreaking STEMI-DTU Clinical Trial.

Released: 16-Sep-2024 8:55 AM EDT
Arsenic exposure linked to faster onset of diabetes in south Texas population
University of Illinois Chicago

Multiyear study finds that high levels of toxic metals in urine lead to high blood sugar

Released: 16-Sep-2024 8:05 AM EDT
Argon Medical Launches CLEANER Vac™ Thrombectomy System to Remove Blood Clot in the Peripheral Venous Vasculature
Argon Medical Devices, Inc.

Argon Medical Devices, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announced the launch of the CLEANER Vac™ Thrombectomy System for the removal of blood clot from the peripheral venous vasculature.



close
0.15034